Fluphenazine Decanoate Inj Rx

Select the drug indication to add to your list

Fluphenazine Decanoate Inj

Only 4 drugs may be compared at once

Generic Name and Formulations:

Fluphenazine decanoate 25mg/mL; syringe; vial; contains benzyl alcohol.

Select therapeutic use:

Indications for Fluphenazine Decanoate Inj:

Depot parenteral for psychosis.


Initially: 12.5–25mg IM or SC every 4–6 wks; max 100mg/dose.


Not recommended.


Coma. CNS or bone marrow depression. Liver disease. Subcortical brain damage. Blood dyscrasias.


Cardiovascular or renal disease. Pheochromocytoma. Seizures. Glaucoma. History of breast cancer. Exposure to extreme heat or organophosphates. Gradually reduce to lowest effective maintenance dose. Monitor blood, liver, renal, and ocular function. Mental retardation. Surgery. Pregnancy. Nursing mothers.

See Also:


Fluphenazine Concentrate

Fluphenazine Elixir

Fluphenazine Inj

Pharmacological Class:

Piperazine phenothiazine.


Potentiates anticholinergics, CNS depression with alcohol and other CNS depressants; both drugs with propranolol. Antagonized by anticholinergics. Decreased guanethidine effects. May cause false (+) pregnancy test.

Adverse Reactions:

Drowsiness, anticholinergic and other autonomic effects, insomnia, restlessness, rash, photosensitivity, tardive dyskinesia, blood dyscrasias, jaundice, pneumonia, hypertension, retinopathy, lowered seizure threshold, extrapyramidal reactions, neuroleptic malignant syndrome, weight changes, endocrine effects.


Formerly known under the brand names Prolixin (tabs, concentrate, elixir, inj); Permitil (tabs, concentrate); Prolixin Decanoate (decanoate inj).

How Supplied:

Contact supplier.